Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1763-2026

Burlington Medical, Demi Half Aprons. Recall

Burlington Medical, Demi Half Aprons.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Burlington Medical, Demi Half Aprons.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1763-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Feb 11, 2026
FDA report date
Apr 8, 2026
Quantity in commerce
29 units
Distribution
See key details
FDA cause
Process change control

What is being recalled?

Burlington Medical, Demi Half Aprons.

Affected model & UDI checker

Search the exact identifiers published for Z-1763-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
R8DHALFRBurlington Medical, Demi Half Aprons.Check source noticeNot specified
FDA code information

All serial numbers are affected that were manufactured with Xenolite 800 attenuation material from 01/16/2025 to 01/21/2026. 1. Model Number: R8DHALFR; UDI-DI (Product Code): 00197513001485 (DHALF8-R8DHALFR-L), 00197513001478 (DHALF8-R8DHALFR-M), 00197513001461 (DHALF8-R8DHALFR-S), 00197513001492 (DHALF8-R8DHALFR-XL), 00197513001607 (DHALFSET8-R8DHALFR-SET).

View the original FDA recall notice

Why was this product recalled?

Potential for attenuation degradation over time, decreasing the lifespan.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did BURLINGTON MEDICAL, LLC take?

Burlington Medical notified consignees on about 02/11/2026 via "URGENT - FIELD SAFETY NOTICE (FSN)" letter. Consignees were instructed to ensure all users of the specific Burlington Medical radiation protection garments made aware of this Recall Notice, review inventory for affected units, arrange for the return of those affected units for proper disposal, and complete and return the Recall Response Form. Consignees were also instructed to notify appropriate individuals within your organization and to any organization where the potentially affected devices were transferred or sold.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology